Virtuosis AI, an EPFL spinoff and recipient of Microsoft’s Startup of the Year 2023 award, leverages AI-powered vocal biomarkers to detect over 25 mental, cognitive, respiratory, cardiovascular, and metabolic disorders from just a 30-second voice recording.
Virtuosis is advancing vocal biomarker technology integration into telemedicine and digital therapeutics platforms to enhance health screening, diagnostics, and patient monitoring. The company collaborates with occupational health firms, hospitals, and research institutions to further validate biomarkers. Virtuosis operates in Switzerland, France, Germany, the UK, Canada, and the UAE.
Virtuosis
Bâtiment Phenyl – DH2
Route de la Corniche 3
1066 Epalinges
Keywords
